Edwards Lifesciences
NYSE EW · Irvine, CA
Works in Cardiovascular · Genetic & rare · GI & liver · Hematology · Immunology · Oncology · Respiratory
Edwards Lifesciences is a clinical trial sponsor based in Irvine, CA, listed as NYSE EW. It has 46 active clinical trials with 20,417 planned participants, across 7 therapeutic areas. Since 2021 it has completed 39 trials and stopped 9 early.
Trial track record · since 2021
Financials · NYSE EW
Pipeline · 46 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Edwards Lifesciences
Edwards Lifesciences is lead sponsor of 46 active clinical trials on ClinicalTrials.gov, with 20,417 planned participants, in Cardiovascular, Genetic & rare, GI & liver, Hematology and other areas. Since 2021 it has completed 39 trials and stopped 9 early.
Edwards Lifesciences is based in Irvine, CA and is listed as NYSE EW. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Edwards Lifesciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-07.
Approve Suite is not affiliated with Edwards Lifesciences.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.